This guidance is intended to help inform the design and implementation of natural history studies that can be used to support the development of safe and effective drugs and biological products
for rare diseases. Although the focus of this guidance is rare diseases; the recommendations in the guidance may be applicable to drug development for nonrare diseases.
Rare Diseases: Natural
History Studies for
Drug Development Guidance for Industry
Published by FDA
Rare DiseaseNatural History